Drug profile · INN
zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)
AFLUNOV
zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) (AFLUNOV) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J07) J07BB02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) (AFLUNOV) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)
Brand AFLUNOV
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BB02
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)?
zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) (AFLUNOV) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted)?
AFLUNOV is a marketed brand name for zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted). Check FDA Drugs@FDA for the current US label holder and prescribing information.